BMRN vs TTC · P/E 40, rev $1.76B vs P/E 26, rev $3.69B
Biomarin Pharmaceutical Inc (BMRN) versus Toro Co (TTC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Toro Co (TTC) is a tools & accessories company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TTC revenue for 2026-07-31 was $3.69B. Net income was $290.3M. Revenue was up 49.8% from 2026-05-01 to 2026-07-31. TTC currently screens at market cap $8.65B and trailing P/E 26.2.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TTC currently screens at market cap $8.65B and trailing P/E 26.2.
Not investment advice. Open the BMRN and TTC stock pages for the full models.
Not investment advice.